OnKure Therapeutics (OKUR) Price to Book (2021 - 2026)

OnKure Therapeutics (OKUR) has reported Price to Book for 6 consecutive years, with 1.07 the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Price to Book rose 173.22% year-over-year to 1.07; the trailing twelve-month figure through Jun 2026 stood at 1.07 (up 173.22% YoY), and the FY2025 full-year result was 0.71, down 36.16% from the prior year.
• Price to Book rose to 1.07 in Q2 2026 per OKUR's latest filing, from 0.31 in the prior quarter.
• Across five years, Price to Book topped out at 9.16 in Q1 2023 and bottomed at 2.1 in Q4 2023.
• Historically, Price to Book has averaged 1.26 across 5 years, with a median of 0.53 in 2022.
• The sharpest annual moves came in 2022 and 2023: Price to Book sank 200.36% in 2022, then jumped 1623.76% in 2023.
• Over 5 years, Price to Book stood at 1.06 in 2022, then slumped by 98.17% to 2.1 in 2023, then jumped by 152.75% to 1.11 in 2024, then slumped by 36.16% to 0.71 in 2025, then soared by 52.02% to 1.07 in 2026.
• According to Business Quant data, Price to Book over the past three periods registered 1.07, 0.31, and 0.71 for Q2 2026, Q1 2026, and Q4 2025 respectively.